Clinical trial
The Effect of an Angiotensin Converting Enzyme Inhibitor on Aortic Wall Properties in Patients With Marfan Syndrome.
NCT00485368 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of an Angiotensin Converting Enzyme Inhibitor on Aortic Wall Properties in Patients With Marfan Syndrome.
- Lead sponsor
- Bayside Health
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- September 30, 2006
- Enrollment
- 17 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.